• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌氧化磷酸化相关基因特征的建立与验证。

Development and validation of an oxidative phosphorylation-related gene signature in lung adenocarcinoma.

机构信息

Department of Thoracic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, PR China.

Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330031, PR China.

出版信息

Epigenomics. 2020 Aug;12(15):1333-1348. doi: 10.2217/epi-2020-0217. Epub 2020 Aug 13.

DOI:10.2217/epi-2020-0217
PMID:32787683
Abstract

To develop an oxidative phosphorylation (OXPHOS)-related gene signature of lung adenocarcinoma (LUAD). We split The Cancer Genome Atlas LUAD cohort into a training set and a test set; we used the least absolute shrinkage and selection operator Cox method to structure the OXPHOS-related prognostic signature in the training set and verified in the test set and GSE30219 dataset. Meanwhile, the diagnostic model was constructed using the logistic Cox method. The signature consisted of seven genes (, , , , , , and ). LUAD patients were divided into high- and low-risk groups, demonstrating good diagnostic and prognostic capabilities. We developed the first-ever OXPHOS-related signature with both prognostic predictive power and diagnostic efficacy.

摘要

构建肺腺癌(LUAD)的氧化磷酸化(OXPHOS)相关基因特征。我们将癌症基因组图谱 LUAD 队列分为训练集和测试集;我们使用最小绝对值收缩和选择算子 Cox 方法在训练集中构建 OXPHOS 相关预后特征,并在测试集和 GSE30219 数据集中进行验证。同时,使用逻辑 Cox 方法构建诊断模型。该特征由 7 个基因(,,,,,,和)组成。LUAD 患者被分为高风险组和低风险组,表现出良好的诊断和预后能力。我们首次开发了具有预后预测能力和诊断疗效的 OXPHOS 相关特征。

相似文献

1
Development and validation of an oxidative phosphorylation-related gene signature in lung adenocarcinoma.肺腺癌氧化磷酸化相关基因特征的建立与验证。
Epigenomics. 2020 Aug;12(15):1333-1348. doi: 10.2217/epi-2020-0217. Epub 2020 Aug 13.
2
Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.早期肺腺癌中一种稳健的免疫相关预后标志物的开发与验证
J Transl Med. 2020 Oct 7;18(1):380. doi: 10.1186/s12967-020-02545-z.
3
Development of a gene signature associated with iron metabolism in lung adenocarcinoma.肺腺癌中铁代谢相关基因标志物的开发。
Bioengineered. 2021 Dec;12(1):4556-4568. doi: 10.1080/21655979.2021.1954840.
4
Identification of 5-Gene Signature Improves Lung Adenocarcinoma Prognostic Stratification Based on Differential Expression Invasion Genes of Molecular Subtypes.基于分子亚型差异表达侵袭基因的 5 基因特征识别可改善肺腺癌的预后分层。
Biomed Res Int. 2020 Dec 31;2020:8832739. doi: 10.1155/2020/8832739. eCollection 2020.
5
A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.一个新的与铁死亡相关的基因签名,用于预测肺腺癌患者的预后。
Aging (Albany NY). 2021 Jun 11;13(12):16144-16164. doi: 10.18632/aging.203140.
6
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.鉴定出一种免疫特征,可预测肺腺癌患者的预后风险。
J Transl Med. 2019 Mar 4;17(1):70. doi: 10.1186/s12967-019-1824-4.
7
A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.一个与免疫密切相关的七基因标志物被鉴定出来,可用于预测肺腺癌的生存。
Med Sci Monit. 2020 Jul 2;26:e924269. doi: 10.12659/MSM.924269.
8
Eight-gene signature predicts recurrence in lung adenocarcinoma.八基因标志物预测肺腺癌复发。
Cancer Biomark. 2020;28(4):447-457. doi: 10.3233/CBM-190329.
9
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).一种七基因预后特征可预测肺腺癌(LUAD)患者的总生存期。
Cancer Cell Int. 2021 Jun 6;21(1):294. doi: 10.1186/s12935-021-01975-z.
10
A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.双环状 RNA 特征作为肺腺癌的非侵入性诊断生物标志物。
J Transl Med. 2019 Feb 18;17(1):50. doi: 10.1186/s12967-019-1800-z.

引用本文的文献

1
Prognostic value of oxidative phosphorylation-related genes in hepatocellular carcinoma.氧化磷酸化相关基因在肝细胞癌中的预后价值
Discov Oncol. 2024 Jul 3;15(1):258. doi: 10.1007/s12672-024-01129-3.
2
Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma.METTL7A基因在肺腺癌预后中的意义的综合分析
Front Oncol. 2022 Dec 23;12:1071100. doi: 10.3389/fonc.2022.1071100. eCollection 2022.
3
Crosstalk of Oxidative Phosphorylation-Related Subtypes, Establishment of a Prognostic Signature and Immune Infiltration Characteristics in Colorectal Adenocarcinoma.
氧化磷酸化相关亚型的串扰、结直肠癌预后特征的建立及免疫浸润特性
Cancers (Basel). 2022 Sep 16;14(18):4503. doi: 10.3390/cancers14184503.
4
Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer.癌胚抗原作为肺癌诊断、预后和治疗的生物标志物及靶点
Front Oncol. 2022 Apr 27;12:864159. doi: 10.3389/fonc.2022.864159. eCollection 2022.
5
Exploring YAP1-centered networks linking dysfunctional CFTR to epithelial-mesenchymal transition.探讨以 YAP1 为中心的网络将功能失调的 CFTR 与上皮间质转化联系起来。
Life Sci Alliance. 2022 May 2;5(9). doi: 10.26508/lsa.202101326. Print 2022 Sep.
6
Immunotherapeutic Value of MAP1LC3C and Its Candidate FDA-Approved Drugs Identified by Pan-Cancer Analysis, Virtual Screening and Sensitivity Analysis.通过泛癌分析、虚拟筛选和敏感性分析确定的MAP1LC3C及其候选FDA批准药物的免疫治疗价值
Front Pharmacol. 2022 Mar 2;13:863856. doi: 10.3389/fphar.2022.863856. eCollection 2022.
7
Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma.子宫体子宫内膜癌中氧化磷酸化相关及免疫微环境预后标志物的开发
Front Cell Dev Biol. 2021 Nov 25;9:753004. doi: 10.3389/fcell.2021.753004. eCollection 2021.
8
A five-m6A regulatory gene signature is a prognostic biomarker in lung adenocarcinoma patients.一个五甲基胞嘧啶调控基因特征是肺腺癌患者的预后生物标志物。
Aging (Albany NY). 2021 Mar 26;13(7):10034-10057. doi: 10.18632/aging.202761.
9
Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.基于肺腺癌差异表达免疫基因的优化预后模型构建。
BMC Cancer. 2021 Mar 1;21(1):213. doi: 10.1186/s12885-021-07911-8.